Hepatitis B-CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

被引:2
作者
Russ, Rachel K. [1 ]
Vandehei, Haley M. [2 ]
Golovkina, Maria, I [1 ]
Mogallapalli, Harshitha [3 ]
Caldera, Freddy [3 ]
Hayney, Mary S. [1 ]
机构
[1] Univ Wisconsin Madison, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA
[2] UW Hlth, Employee Hlth Serv, Madison, WI USA
[3] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Div Gastroenterol & Hepatol, Madison, WI USA
关键词
hepatitis B vaccine; healthcare workers; nonresponders; seroprotections; hepatitis B vaccine-CpG adjuvant;
D O I
10.1093/cid/ciae320
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This prospective study enrolled healthcare workers (HCWs) who were nonresponders following at least 5 doses of aluminum-adjuvanted hepatitis B vaccine who received the 2-dose Heplisav-B (HepB-CpG) (Dynavax Technologies Corporation, Emeryville, CA) series. After 2 doses of HepB-CpG, 43/47 (91%) participants, and with 1 dose, 41/49 (84%) responded. HepB-CpG could be the preferred vaccine in HCW nonresponders.Clinical Trials Registration. Clinicaltrials.gov NCT04456504.
引用
收藏
页码:562 / 563
页数:2
相关论文
共 5 条
[1]  
Hepatitis B Foundation, 2021, VACCINE NONRESPONDER
[2]   Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV [J].
Khaimova, Rebecca ;
Fischetti, Briann ;
Cope, Rebecca ;
Berkowitz, Leonard ;
Bakshi, Anjali .
VACCINE, 2021, 39 (44) :6529-6534
[3]  
Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1
[4]   Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine [J].
Stevenson, Catherine ;
Youn, Ji-Hee ;
Hayney, Mary S. ;
David, Coline .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) :4567-4577
[5]   Heplisav-B in Prior Hepatitis B Vaccine Nonresponders: A Case Series [J].
Williams, Alan L. .
MILITARY MEDICINE, 2022, 187 (7-8) :E811-E813